Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1

被引:674
|
作者
Opferman, JT [1 ]
Letai, A [1 ]
Beard, C [1 ]
Sorcinelli, MD [1 ]
Ong, CC [1 ]
Korsmeyer, SJ [1 ]
机构
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA
关键词
D O I
10.1038/nature02067
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Regulated apoptosis is essential for both the development and the subsequent maintenance of the immune system(1,2). Interleukins, including IL- 2, IL- 4, IL- 7 and IL- 15, heavily influence lymphocyte survival during the vulnerable stages of VDJ rearrangement and later in ensuring cellular homeostasis, but the genes specifically responsible for the development and maintenance of lymphocytes have not been identified(3 - 8). The antiapoptotic protein MCL- 1 is an attractive candidate, as it is highly regulated(9), appears to enhance short- term survival(10) and functions at an apical step in genotoxic deaths(11). However, Mcl- 1 deficiency results in peri- implantation lethality(12). Here we show that mice conditional for Mcl- 1 display a profound reduction in B and T lymphocytes when MCL- 1 is removed. Deletion of Mcl- 1 during early lymphocyte differentiation increased apoptosis and arrested the development at pro- B- cell and double- negative T- cell stages. Induced deletion of Mcl- 1 in peripheral B- and T- cell populations resulted in their rapid loss. Moreover, IL- 7 both induced and required MCL- 1 to mediate lymphocyte survival. Thus, MCL- 1, which selectively inhibits the proapoptotic protein BIM, is essential both early in lymphoid development and later on in the maintenance of mature lymphocytes.
引用
收藏
页码:671 / 676
页数:6
相关论文
共 50 条
  • [31] Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes
    Lomo, J
    Smeland, EB
    Krajewski, S
    Reed, JC
    Blomhoff, HK
    CANCER RESEARCH, 1996, 56 (01) : 40 - 43
  • [32] The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients
    Andersen, MH
    Becker, JC
    Straten, PT
    LEUKEMIA, 2005, 19 (03) : 484 - 485
  • [33] Regulation of antiapoptotic MCL-1 function by gossypol: Mechanistic insights from in vitro reconstituted systems
    Etxebarria, Aitor
    Landeta, Olatz
    Antonsson, Bruno
    Basanez, Gorka
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) : 1563 - 1576
  • [34] The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients
    M H Andersen
    J C Becker
    P thor Straten
    Leukemia, 2005, 19 : 484 - 485
  • [35] Coxiella burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1
    Cherla, Rama
    Zhang, Yan
    Ledbetter, Lindsey
    Zhang, Guoquan
    INFECTION AND IMMUNITY, 2018, 86 (04)
  • [36] MCL-1V, a novel mouse antiapoptotic MCL-1 variant, generated by RNA splicing at a non-canonical splicing pair
    Kojima, Shogo
    Hyakutake, Akira
    Koshikawa, Nobuko
    Nakagawara, Akira
    Takenaga, Keizo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 492 - 497
  • [37] Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1)
    Beekman, Andrew M.
    O'Connell, Maria A.
    Howell, Lesley A.
    CHEMMEDCHEM, 2016, 11 (08) : 840 - 844
  • [38] Herceptin sensitizes ErbB2 - Overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression
    Henson, ES
    Hu, XJ
    Gibson, SB
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 845 - 853
  • [39] miR-193b Regulates Mcl-1 in Melanoma
    Chen, Jiamin
    Zhang, Xiao
    Lentz, Cindy
    Abi-Daoud, Marie
    Pare, Genevieve C.
    Yang, Xiaolong
    Feilotter, Harriet E.
    Tron, Victor A.
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (05): : 2162 - 2168
  • [40] Recent advances in the development of Mcl-1 inhibitors for cancer therapy
    Hird, Alexander W.
    Tron, Adriana E.
    PHARMACOLOGY & THERAPEUTICS, 2019, 198 : 59 - 67